Gilead Sciences
GILD
$80.73
Share price
1.45%
Change (1 day)
36.41%
Change (1 year)
Categories
Gilead Sciences (GILD) Fails to deliver data
Key failure to deliver metrics for Gilead Sciences:
- Last SEC data release: 2023-02-28
- Last 15 days FTD volume: $5.71 M
- Last 3 months FTD volume: $33.96 M
- Last year FTD volume: $0.28 B
Failures to deliver for Gilead Sciences (GILD) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013
Volume in USD (price x number of shares), data since 2013Gilead Sciences (GILD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $30.1 M | -88.75% |
| 2022 | $0.26 B | 97.85% |
| 2021 | $0.13 B | -41.09% |
| 2020 | $0.22 B | 93.47% |
| 2019 | $0.11 B | -83.14% |
| 2018 | $0.70 B | 537.75% |
| 2017 | $0.11 B | -73.45% |
| 2016 | $0.41 B | -10.96% |
| 2015 | $0.46 B | -44.68% |
| 2014 | $0.84 B | 249.24% |
| 2013 | $0.24 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $66.53 M | $0.31 B | 🇺🇸 USA |
 Pfizer PFE | $0.23 B | $0.56 B | 🇺🇸 USA |
 AbbVie ABBV | $0.13 B | $0.43 B | 🇺🇸 USA |
 Eli Lilly LLY | $42.87 M | $0.29 B | 🇺🇸 USA |
 Amgen AMGN | $81.07 M | $0.51 B | 🇺🇸 USA |
 Biogen BIIB | $8.79 M | $65.55 M | 🇺🇸 USA |
 Illumina ILMN | $3.47 M | $50.24 M | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $45.72 M | $0.18 B | 🇺🇸 USA |
 Merck MRK | $0.24 B | $0.58 B | 🇺🇸 USA |